Image Trademark of Map Pharmaceuticals, Inc. Trademark Details
Status | Dead 606 — Abandoned - No Statement of Use Filed |
---|
Current Owner
Map Pharmaceuticals, Inc. of Mountain View, CA
View all trademarks for Map Pharmaceuticals, Inc.Serial Number | 77307521 |
---|---|
Status Date | Tuesday, July 5, 2011 |
Filing Date | Tuesday, July 5, 2011 |
Attorney | Jennifer Lee Taylor |
Correspondent
Jennifer Lee Taylor
MORRISON & FOERSTER LLP
425 MARKET STREET
SAN FRANCISCO CA 94105-2482
MORRISON & FOERSTER LLP
425 MARKET STREET
SAN FRANCISCO CA 94105-2482
Case File Statements
Indication of Colors | Color is not claimed as a feature of the mark. |
---|---|
Description of Mark | The mark consists of a circular design with two intersecting curved lines. |
Goods & Services | Pharmaceutical products for use in the treatment of cardiovascular diseases and disorders, urological diseases and disorders, gastrointestinal diseases and disorders, musculoskeletal diseases and disorders, hypertension, inflammation and inflammatory diseases and disorders, metabolic diseases and disorders, infectious diseases and disorders, immunological, bacterial, viral and fungal diseases and disorders, psychiatric diseases and disorders, allergies, diabetes, obesity, stroke, erectile and sexual dysfunction, and hemolytic diseases and disorders; pharmaceutical preparations, namely, cholesterol preparations, osteoporosis preparations, oncological preparations, dermatological preparations, ophthalmologic preparations, smoking cessation preparations, tissue and skin repair preparations and gynecological preparations; drug delivery devices, namely, inhalers containing pre-filled drug cartridges which deliver medication in liquid form via the pulmonary route, either directly to the lungs or for absorption and delivery in systemic circulation for use in the treatment of cardiovascular diseases and disorders, urological diseases and disorders, gastrointestinal diseases and disorders, musculoskeletal diseases and disorders, hypertension, inflammation and inflammatory diseases and disorders, metabolic diseases and disorders, infectious diseases and disorders, immunological, bacterial, viral and fungal diseases and disorders, psychiatric diseases and disorders, allergies, diabetes, obesity, stroke, erectile and sexual dysfunction, and hemolytic diseases and disorders; drug delivery devices, namely, inhalers containing pre-filled drug cartridges which deliver medication in liquid form via the pulmonary route, either directly to the lungs or for absorption and delivery in systemic circulation for use in the delivery of cholesterol preparations, osteoporosis preparations, oncological preparations, dermatological preparations, ophthalmologic preparations, smoking cessation preparations, tissue and skin repair preparations and gynecological preparations |
Goods & Services | Pharmaceutical research and development; research and development of pharmaceutical preparations for the treatment of cardiovascular diseases and disorders, central nervous system and neurological diseases and disorders, urological diseases and disorders, gastrointestinal diseases and disorders, musculoskeletal diseases and disorders, migraines and headaches, pain, hypertension, inflammation and inflammatory diseases and disorders, metabolic diseases and disorders, respiratory and infectious diseases and disorders, immunological, bacterial, viral and fungal diseases and disorders, psychiatric diseases and disorders, asthma, allergies, diabetes, obesity, stroke, erectile and sexual dysfunction, and hemolytic diseases and disorders; research and development of pharmaceutical preparations, namely, cholesterol preparations, osteoporosis preparations, oncological preparations, dermatological preparations, ophthalmologic preparations, smoking cessation preparations, tissue and skin repair preparations and gynecological preparations; research and development of drug delivery devices, both with and without pre-filled drug cartridges, for delivery of medication via the pulmonary route; medical and scientific research, namely, conducting clinical trials |
Classifications
International Class Codes |
005
|
---|---|
U.S. Class Codes | 006, 018, 044, 046, 051, 052 |
Status | 6 — Active |
Status Date | Tuesday, October 23, 2007 |
Primary Code | 005 |
International Class Codes |
042
|
---|---|
U.S. Class Codes | 100, 101 |
Status | 6 — Active |
Status Date | Tuesday, October 23, 2007 |
Primary Code | 042 |
Trademark Timeline
-
Oct 18 2007Trademark application filed with USPTO
-
Oct 23 2007New Application Entered In Tram
-
Oct 24 2007Notice of Design Search Code Mailed
-
Nov 01 2007International filing request made
-
Nov 01 2007New Application For Ir Received
-
Nov 02 2007Manually Certified
-
Nov 02 2007Ir Certified and Sent To Ib
-
Nov 15 2007Teas Voluntary Amendment Received
-
Dec 26 2007Teas/email Correspondence Entered
-
Dec 26 2007Correspondence Received In Law Office
-
Dec 26 2007Assigned To Lie
-
Jan 04 2008Irregularity Notice Received From Ib
-
Jan 29 2008Assigned To Examiner
-
Jan 30 2008Approved For Pub - Principal Register
-
Jan 30 2008Examiner's Amendment Entered
-
Jan 30 2008Examiners Amendment -Written
-
Jan 31 2008Examiner's Amendment Mailed
-
Feb 01 2008Law Office Publication Review Completed
-
Feb 20 2008Notice of Publication
-
Mar 11 2008Published For Opposition
-
Apr 03 2008Irregularity Response Received From Applicant
-
Apr 04 2008Response To Irregularity Reviewed and Accepted
-
Apr 04 2008Irregularity Response Sent To Ib
-
Jun 03 2008Noa Mailed - Sou Required From Applicant
-
Sep 04 2008Application For Ir Registered By Ib
-
Nov 13 2008Divisional Request Received
-
Nov 13 2008Extension 1 Filed
-
Nov 13 2008Teas Extension Received
-
Nov 17 2008Paper Received
-
Nov 17 2008Case Assigned To Intent To Use Paralegal
-
Nov 18 2008Divisional Processing Complete
-
Nov 18 2008Extension 1 Granted
-
Nov 19 2008Divisional of Base App Notice Created, To Be Sent To Ib
-
Nov 19 2008Divisional of Base App Notice Sent To Ib
-
Dec 13 2008Division of Base Application Processed By Ib
-
May 19 2009Extension 2 Filed
-
May 19 2009Teas Extension Received
-
May 20 2009Extension 2 Granted
-
Jun 04 2009Partial Ceasing of Effect To Be Processed
-
Jun 19 2009Ceasing of Effect Reviewed - No Action Required By Office
-
Nov 06 2009Extension 3 Filed
-
Nov 06 2009Teas Extension Received
-
Nov 09 2009Extension 3 Granted
-
Apr 23 2010Extension 4 Filed
-
Apr 23 2010Teas Extension Received
-
Apr 26 2010Extension 4 Granted
-
Apr 27 2010Notice of Approval of Extension Request Mailed
-
Sep 01 2010Extension 5 Filed
-
Sep 01 2010Teas Extension Received
-
Sep 03 2010Extension 5 Granted
-
Sep 04 2010Notice of Approval of Extension Request Mailed
-
Jul 05 2011Abandonment Notice Mailed - No Use Statement Filed
-
Jul 05 2011Abandonment - No Use Statement Filed
-
Jan 05 2012Partial Ceasing of Effect To Be Processed
-
Apr 06 2012Ceasing of Effect Processed
-
Apr 06 2012Partial Ceasing of Effect Notice Sent To Ib
-
Jun 21 2013Change of Owner Received From Ib